Literature DB >> 20821241

Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3β.

G Ekin Atilla-Gokcumen1, Luigi Di Costanzo, Eric Meggers.   

Abstract

The 3.15-Å-resolution crystal structure of the R enantiomer of the highly bioactive and antiproliferative half-sandwich ruthenium complex DW12 bound to the ATP binding site of glycogen synthase kinase 3β (GSK-3β) is reported and the binding is compared with the GSK-3β binding of staurosporine and other organic inhibitors. The structure reveals a close packing of the organometallic inhibitor in the ATP binding site of GSK-3β via an induced-fit mechanism. The molecular structure of (R)-DW12 with the CO ligand oriented perpendicular to the pyridocarbazole heterocycle allows the complex to stretch the whole distance sandwiched between the faces of the N- and C-terminal lobes and to interact tightly with the flexible glycine-rich loop, which is uncommon for the interaction of GSK-3β with organic inhibitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20821241     DOI: 10.1007/s00775-010-0699-x

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  27 in total

1.  On the computation of the fast rotation function.

Authors:  J Navaza
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1993-11-01

2.  Switching on a signaling pathway with an organoruthenium complex.

Authors:  Douglas S Williams; G Ekin Atilla; Howard Bregman; Arpine Arzoumanian; Peter S Klein; Eric Meggers
Journal:  Angew Chem Int Ed Engl       Date:  2005-03-18       Impact factor: 15.336

3.  Rapid access to unexplored chemical space by ligand scanning around a ruthenium center: discovery of potent and selective protein kinase inhibitors.

Authors:  Howard Bregman; Patrick J Carroll; Eric Meggers
Journal:  J Am Chem Soc       Date:  2006-01-25       Impact factor: 15.419

4.  Structural diversity of organic chemistry. A scaffold analysis of the CAS Registry.

Authors:  Alan H Lipkus; Qiong Yuan; Karen A Lucas; Susan A Funk; William F Bartelt; Roger J Schenck; Anthony J Trippe
Journal:  J Org Chem       Date:  2008-05-28       Impact factor: 4.354

5.  An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.

Authors:  Keiran S M Smalley; Rooha Contractor; Nikolas K Haass; Angela N Kulp; G Ekin Atilla-Gokcumen; Douglas S Williams; Howard Bregman; Keith T Flaherty; Maria S Soengas; Eric Meggers; Meenhard Herlyn
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

6.  Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3.

Authors:  Han-Cheng Zhang; Llorente V R Boñaga; Hong Ye; Claudia K Derian; Bruce P Damiano; Bruce E Maryanoff
Journal:  Bioorg Med Chem Lett       Date:  2007-02-25       Impact factor: 2.823

7.  The crystal structure of BRAF in complex with an organoruthenium inhibitor reveals a mechanism for inhibition of an active form of BRAF kinase.

Authors:  Peng Xie; Craig Streu; Jie Qin; Howard Bregman; Nicholas Pagano; Eric Meggers; Ronen Marmorstein
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

8.  Structure-based design of an organoruthenium phosphatidyl-inositol-3-kinase inhibitor reveals a switch governing lipid kinase potency and selectivity.

Authors:  Peng Xie; Douglas S Williams; G Ekin Atilla-Gokcumen; Leslie Milk; Min Xiao; Keiran S M Smalley; Meenhard Herlyn; Eric Meggers; Ronen Marmorstein
Journal:  ACS Chem Biol       Date:  2008-05-16       Impact factor: 5.100

9.  Extremely tight binding of a ruthenium complex to glycogen synthase kinase 3.

Authors:  G Ekin Atilla-Gokcumen; Nicholas Pagano; Craig Streu; Jasna Maksimoska; Panagis Filippakopoulos; Stefan Knapp; Eric Meggers
Journal:  Chembiochem       Date:  2008-12-15       Impact factor: 3.164

10.  GSK-3-selective inhibitors derived from Tyrian purple indirubins.

Authors:  Laurent Meijer; Alexios-Leandros Skaltsounis; Prokopios Magiatis; Panagiotis Polychronopoulos; Marie Knockaert; Maryse Leost; Xiaozhou P Ryan; Claudia Alin Vonica; Ali Brivanlou; Rana Dajani; Claudia Crovace; Cataldo Tarricone; Andrea Musacchio; S Mark Roe; Laurence Pearl; Paul Greengard
Journal:  Chem Biol       Date:  2003-12
View more
  10 in total

1.  Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition.

Authors:  Sebastian Blanck; Yann Geisselbrecht; Katja Kräling; Stephen Middel; Thomas Mietke; Klaus Harms; Lars-Oliver Essen; Eric Meggers
Journal:  Dalton Trans       Date:  2012-06-26       Impact factor: 4.390

2.  Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors.

Authors:  Li Feng; Yann Geisselbrecht; Sebastian Blanck; Alexander Wilbuer; G Ekin Atilla-Gokcumen; Panagis Filippakopoulos; Katja Kräling; Mehmet Ali Celik; Klaus Harms; Jasna Maksimoska; Ronen Marmorstein; Gernot Frenking; Stefan Knapp; Lars-Oliver Essen; Eric Meggers
Journal:  J Am Chem Soc       Date:  2011-03-29       Impact factor: 15.419

3.  An organometallic inhibitor for the human repair enzyme 7,8-dihydro-8-oxoguanosine triphosphatase.

Authors:  Manuel Streib; Katja Kräling; Kristin Richter; Xiulan Xie; Holger Steuber; Eric Meggers
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-20       Impact factor: 15.336

4.  Hydrogen bonding and anticancer properties of water-soluble chiral p-cymene Ru(II) compounds with amino-oxime ligands.

Authors:  Yosra Benabdelouahab; Laura Muñoz-Moreno; Malgorzata Frik; Isabel de la Cueva-Alique; Mohammed Amin El Amrani; María Contel; Ana M Bajo; Tomás Cuenca; Eva Royo
Journal:  Eur J Inorg Chem       Date:  2015-04-09       Impact factor: 2.524

5.  Anticancer Activity of Self-Assembled Molecular Rectangles via Arene-Ruthenium Acceptors and a New Unsymmetrical Amide Ligand.

Authors:  Anurag Mishra; Hyunji Jung; Jeong Woo Park; Hong Kyeung Kim; Hyunuk Kim; Peter J Stang; Ki-Whan Chi
Journal:  Organometallics       Date:  2012-04-13       Impact factor: 3.876

6.  Self-assembled supramolecular hetero-bimetallacycles for anticancer potency by intracellular release.

Authors:  Anurag Mishra; Seung Chang Lee; Neha Kaushik; Timothy R Cook; Eun Ha Choi; Nagendra Kumar Kaushik; Peter J Stang; Ki-Whan Chi
Journal:  Chemistry       Date:  2014-09-10       Impact factor: 5.236

7.  Mirror-image organometallic osmium arene iminopyridine halido complexes exhibit similar potent anticancer activity.

Authors:  Ying Fu; Rina Soni; María J Romero; Ana M Pizarro; Luca Salassa; Guy J Clarkson; Jessica M Hearn; Abraha Habtemariam; Martin Wills; Peter J Sadler
Journal:  Chemistry       Date:  2013-09-23       Impact factor: 5.236

8.  An iridium(iii)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent.

Authors:  Hai-Jing Zhong; Lihua Lu; Ka-Ho Leung; Catherine C L Wong; Chao Peng; Siu-Cheong Yan; Dik-Lung Ma; Zongwei Cai; Hui-Min David Wang; Chung-Hang Leung
Journal:  Chem Sci       Date:  2015-07-30       Impact factor: 9.825

9.  Ruthenacarborane-Phenanthroline Derivatives as Potential Metallodrugs.

Authors:  Martin Kellert; Imola Sárosi; Rajathees Rajaratnam; Eric Meggers; Peter Lönnecke; Evamarie Hey-Hawkins
Journal:  Molecules       Date:  2020-05-15       Impact factor: 4.411

10.  Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models.

Authors:  Thomas Kramer; Boris Schmidt; Fabio Lo Monte
Journal:  Int J Alzheimers Dis       Date:  2012-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.